Skip to main content
. 2022 Nov 15;22:457. doi: 10.1186/s12876-022-02513-5

Table 1.

Demographic data and diagnostic test results of the 50 enrolled patients

Characteristics control group remission group active group
Age (Years), Mean ± SD 31.15 ± 5.89 27.09 ± 6.59 27.54 ± 6.44
Gender, n (%)
Male 9(45.0%) 17(53.1%) 15(53.6%)
Female 11(55.0%) 15(46.9%) 13(46.4%)
Course (Years), Mean ± SD 3.65 ± 2.45 3.96 ± 2.44
Location
Ileum, n (%) 2(6.2%) 1(3.6%)
Ileocolon, n (%) 18(56.3%) 22(78.6%)
Colon, n(%) 12(37.5%) 5(17.8%)
Classification
Penetrating, n(%) 5(15.6%) 7(25.0%)
Stricturing, n(%) 21(65.6%) 16(57.2%)
Non-stricturing & non-penetrating, n(%) 6(18.8%) 5(17.8%)
Perianally lesions, n(%) 3(9.4%) 6(21.4%)
Operation history, n(%) 5(16.6%) 9(32.1%)
Smoking history, n(%) 2(10.0%) 4(12.5%) 6(21.4%)
Best CDAI Score, Mean ± SD 19.35 ± 10.97 102.09 ± 28.79 329.83 ± 108.69
SES-CD Score, Mean ± SD 1.45 ± 0.94 15.07 ± 3.26 6.43 ± 1.68
MaRIA Score, Mean ± SD 3.51 ± 1.86 12.14 ± 1.22 49.77 ± 13.46
Laboratory tests
ESR (mm/h) ,Mean ± SD 5.60 ± 2.11 15.01 ± 4.80 36.50 ± 8.22
CRP (mg/L), Mean ± SD 6.25 ± 2.24 23.03 ± 4.76 65.85 ± 14.12
WBC (×109/L), Mean ± SD 6.43 ± 1.28 8.72 ± 1.21 13.95 ± 1.65
HB (g/L), Mean ± SD 132.95 ± 9.13 95.73 ± 9.58 70.60 ± 9.46
HCT (%), Mean ± SD 40.17 ± 2.97 34.17 ± 2.84 29.29 ± 1.95
ALB (g/L), Mean ± SD 47.77 ± 4.64 35.71 ± 2.81 28.45 ± 2.12